cpg glp-1 news brands cautiously adopt GLP-1-friendly claims on packaging Reduced spending by GLP-1 users

A 72-week, double-blind phase 2 trial showed that once-daily administration of semaglutide had a significant therapeutic effect on NASH (193)

Overall, cardiovascular arterial events were reduced in patients who were on GLP-1 agonists with JAK inhibitors, vs

The increase was close to 22% between 2023 and 2024

The timeline is pretty predictable: you might feel slightly tired for the first couple hours as your body processes everything, then experience an energy boost that coincides with that coveted glow

Neil Baum, MD Urologist Touro Medical Office New Orleans LA Disclosures NB declares that he has no competing interests